Suche
New hope in prediabetes treatment: homeopathy outperforms placebo
Exciting study shows how individualized homeopathic medicine can help with prediabetes - more successful than placebos! #Health #Prediabetes
New hope in prediabetes treatment: homeopathy outperforms placebo
The most recent research, published in May 2024, looked at the effectiveness of individualized homeopathic medicines (IHMs) compared to placebo in the treatment of prediabetes (PD), a condition that represents a significant disease burden worldwide and increases the risk of stroke, cardiovascular disease and type 2 diabetes mellitus. In this study, conducted over a period of six months in the outpatient departments of a homeopathic medical college and hospital in India, 60 participants with PD were randomized to either a group with the IHMs (30 people) or a placebo group (30 people). In addition, both groups received advice on nutrition, yoga, meditation and exercise.
The main evaluation criteria of the study were fasting blood glucose (FBS) and oral glucose tolerance test (OGTT), while the Diabetes Symptom Checklist-Revised (DSC-R) score was used as a secondary criterion. All outcomes were measured at baseline, after three and after six months of treatment. The researchers found that the IHMs showed significantly better results compared to placebos on FBS and DSC-R score, but not on OGTT. Of note, no harm or serious adverse events were observed among participants.
The results suggest that IHMs may represent an effective treatment option for individuals with PD, particularly in terms of improving FBS scores and quality of life as measured by the DSC-R score. These findings could lead to a review and possible adjustment of existing treatment practices, although independent replication studies with larger samples are needed to confirm the results.
The most important terms and concepts briefly explained:
- Prädiabetes (PD): Ein Gesundheitszustand, bei dem der Blutzuckerspiegel höher als normal ist, aber nicht hoch genug, um als Typ-2-Diabetes diagnostiziert zu werden. Erhöht das Risiko für Typ-2-Diabetes, Herz-Kreislauf-Erkrankungen und Schlaganfälle.
- Homöopathische Medikamente (IHM): Behandlungen, die auf dem Prinzip „Ähnliches möge durch Ähnliches geheilt werden“ basieren, bei denen sehr stark verdünnte Substanzen verwendet werden, von denen angenommen wird, dass sie, wenn sie in höheren Dosen eingenommen werden, ähnliche Symptome wie die zu behandelnde Krankheit hervorrufen könnten.
- Nüchternblutzucker (FBS): Eine Blutprobe, die nach einer nächtlichen Fastenperiode entnommen wird, um den Blutzuckerspiegel zu bestimmen.
- Oraler Glukosetoleranztest (OGTT): Ein Test, der misst, wie gut der Körper Glukose verarbeitet. Dabei wird dem Teilnehmer eine zuckerhaltige Lösung verabreicht und dann zu mehreren Zeitpunkten der Blutzuckerspiegel gemessen.
- Diabetes Symptom Checklist-Revised (DSC-R): Ein Instrument zur Selbsteinschätzung, das verwendet wird, um die Symptome und die Lebensqualität von Personen mit Diabetes oder Prädiabetes zu beurteilen.
This simplified statement is intended to help better understand the significance of these research findings in the context of prediabetes treatment and to recognize their potential role in future medical practice.
Significant improvement in fasting blood sugar levels through individualized homeopathic medication compared to placebo in prediabetes
The present study examined the effectiveness of individualized homeopathic medicines (IHMs) compared to placebo in the treatment of prediabetes, a precursor to more serious diseases such as stroke, cardiovascular disease and type 2 diabetes mellitus. The research aimed to provide new insights into alternative treatments for prediabetes and was conducted in the outpatient departments of a homeopathic medical college and hospital in India over a period of six months using a double-blind, randomized, placebo-controlled trial.
methodology
The study included 60 participants with prediabetes who were randomized to receive either IHMs (n=30) or identical-looking placebos (n=30). Accompanying measures such as nutritional advice, yoga, meditation and exercises were recommended for both groups of participants. The primary outcome measures were fasting blood glucose (FBS) and oral glucose tolerance test (OGTT), while the Diabetes Symptom Checklist-Revised (DSC-R) score served as a secondary outcome. The evaluations took place at the beginning of the study and after 3 and 6 months of treatment. For statistical analysis, intergroup differences and effect sizes (Cohen's d) were calculated using two-way repeated measures analyzes of variance, with baseline differences adjusted using analysis of covariance taking into account intention-to-treat data.
Results
The between-group differences in FBS scores were statistically significant and favored IHMs compared to placebos (F=7.798, P=0.007). However, no significant difference was found in the OGTT values (F=1.691, P=0.199). The DSC-R total score showed a significant improvement in favor of the IHMs compared to the placebos (F=15.752, P<0.001). Lycopodium, Phosphorus and Nux vomica were the most commonly prescribed drugs. No harm or serious adverse events were recorded in either group of participants.
conclusion
The study demonstrates that IHMs performed significantly better than placebos in improving FBS scores and DSC-R scores, but not OGTT scores. These results provide a promising outlook for the use of IHMs in the treatment of prediabetes, but independent replications with larger samples are required to substantiate the findings.